DEXAMETHASONE IN THE PREVENTION OF CHEMOTHERAPY INDUCED EMESIS

被引:0
作者
HOLOYE, P
SCHRECK, I
KALBFLEISCH, J
机构
[1] VET ADM MED CTR,MILWAUKEE,WI
[2] MED COLL WISCONSIN,MILWAUKEE,WI 53193
来源
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1983年 / 24卷 / MAR期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:162 / 162
页数:1
相关论文
共 50 条
[21]   THE CLINICAL ROLE OF GRANISETRON (KYTRIL) IN THE PREVENTION OF CHEMOTHERAPY-INDUCED EMESIS [J].
PEREZ, EA ;
GANDARA, DR .
SEMINARS IN ONCOLOGY, 1994, 21 (03) :15-21
[22]   PREVENTION OF CHEMOTHERAPY-INDUCED EMESIS WITH GRANISETRON IN CHILDREN WITH MALIGNANT DISEASES [J].
MIYAJIMA, Y ;
NUMATA, S ;
KATAYAMA, I ;
HORIBE, K .
AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1994, 16 (03) :236-241
[23]   Efficacy of dexamethasone in prevention of chemotherapy induced disturbance of taste [J].
Tirgan, MA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :763S-763S
[24]   ONDANSETRON PLUS DEXAMETHASONE VS METOCLOPRAMIDE PLUS DEXAMETHASONE PLUS DIPHENHYDRAMINE IN PREVENTION OF CISPLATIN-INDUCED EMESIS [J].
ROILA, F ;
TONATO, M ;
BALLATORI, E ;
PAES, D ;
DELFAVERO, A ;
BASURTO, C ;
BRACARDA, S ;
CORGNA, E ;
PICCIAFUOCO, M ;
PATOIA, L ;
FAVALII, G ;
GARBELLI, R ;
BIANCHI, UA ;
SCARFONE, G ;
FERRARIS, C ;
BOLIS, MC ;
COGNETTI, F ;
CERCATO, A ;
BUZZI, F ;
DELRIO, S ;
SABBATINI, R ;
FEDERICO, M ;
MATERA, G ;
CELLERINO, R ;
DAZZI, C ;
MARANGOLO, M ;
LEONARDI, M ;
CANALETTI, R ;
BABILONTI, L ;
ZARA, C ;
DONATI, D ;
AMADORI, D ;
FERRARI, M .
LANCET, 1992, 340 (8811) :96-99
[25]   Ondansetron vs granisetron, both combined with dexamethasone in the prevention of cisplatin-induced emesis [J].
Roila, F ;
DeAngelis, V ;
Moretti, G ;
Tateo, S ;
Cascinu, S ;
Ionta, MT ;
Montinari, F ;
Morritti, M ;
Pusceddu, G ;
Favalli, G ;
Cortesi, E ;
Dazzi, C ;
Ballatori, E .
EUROPEAN JOURNAL OF CANCER, 1995, 31A :1226-1226
[26]   Ondansetron versus granisetron, both combined with dexamethasone, in the prevention of cisplatin-induced emesis [J].
Basurto, C ;
Ciccarese, G ;
Palladino, MA ;
Picciafuoco, M ;
Ricci, S ;
Antonuzzo, A ;
Allegrini, G ;
Conte, PF ;
Cognetti, F ;
Cirulli, S ;
Colella, E ;
Milella, M ;
Savarese, A ;
Stani, S ;
Contu, A ;
Olmeo, N ;
Piro, S ;
Piras, M ;
Pilo, L ;
Pilo, P ;
Nuzzo, A ;
Ursini, LA ;
Taraborrelli, M ;
Melena, S ;
Basilico, L ;
Buzzi, F ;
Brugia, M ;
Trippa, F ;
DelRio, S ;
Tagliaventi, M ;
Picece, V ;
Cassandrini, P ;
Cirillo, M ;
Magarotto, R ;
Recaldin, E ;
Clerico, M ;
Bartetto, O ;
Morandini, MP ;
Bainotti, L ;
Boni, C ;
Moretti, G ;
Savoldi, L ;
Tateo, S ;
Chiapparini, I ;
Zara, C ;
Catalano, G ;
Cascinu, S ;
Alessandroni, P ;
Massidda, B ;
Ionta, MT .
ANNALS OF ONCOLOGY, 1995, 6 (08) :805-810
[27]   USE OF PROPOFOL FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND EMESIS IN ONCOLOGY PATIENTS [J].
SCHER, CS ;
AMAR, D ;
MCDOWALL, RH ;
BARST, SM .
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1992, 39 (02) :170-172
[28]   COMBINATION METOCLOPRAMIDE AND DIPHENHYDRAMINE SHORT INFUSION FOR PREVENTION OF CHEMOTHERAPY-INDUCED EMESIS [J].
PRZEPIORKA, D ;
KATLUBECK, A ;
TAYLOR, D .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (02) :180-180
[29]   IMPROVED CONTROL OF CHEMOTHERAPY-INDUCED EMESIS BY THE ADDITION OF DEXAMETHASONE TO METOCLOPRAMIDE IN PATIENTS RESISTANT TO METOCLOPRAMIDE [J].
BRUERA, ED ;
ROCA, E ;
CEDARO, L ;
CHACON, R ;
ESTEVEZ, R .
CANCER TREATMENT REPORTS, 1983, 67 (04) :381-383
[30]   Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis [J].
Roila, F .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) :124-130